BRIEF-Glaxosmithkline reaches $105 million settlement with most U.S. states over marketing of drugs
June 4 (Reuters) - GlaxoSmithKline PLC : * Reaches $105 million settlement with most U.S. states over marketing of
various prescription drugs -- U.S. authorities * California, New York attorneys general say settlement resolves allegations
that company unlawfully promoted advair, paxil, wellbutrin * Attorneys general say glaxo settles with 44 U.S. states, Washington d.c.
Trending On Reuters
Strategies for making the most of your donations - from how to grow the money you plan to give to how to withdraw it with minimal tax implications. Video